Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.
Schweitzer
S O
SO
University of California School of Public Health, Los Angeles 90024.
Shiota
S R
SR
D003363:Cost Control; D005069:Evaluation Studies as Topic; D005569:Formularies as Topic / Q000592:standards*; D005102:Health Expenditures; D006297:Health Services Accessibility / Q000191:economics / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D008484:Medicaid / Q000191:economics / Q000331:legislation & jurisprudence*; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence; D013221:State Health Plans / Q000191:economics*; D014481:United States